Valion Bio, Inc. is seeking a reverse stock split to maintain its listing on the Nasdaq stock exchange.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Valion Bio, Inc. is seeking a reverse stock split to maintain its listing on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- C3is Inc. announced a reverse stock split to maintain its listing requirements on the Nasdaq stock exchange.
- The board of directors approved a proposed reverse stock split for a company seeking to maintain its listing on Nasdaq.
- Globaltech Corporation's board initiated a reverse stock split to seek uplisting and meet minimum bid price requirements on Nasdaq.
- Nexalin Technology, Inc. is maintaining its listing compliance on the Nasdaq stock exchange through a reverse stock split.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.